Skip to main content
   
    2000    
 
 
    2018
Billions of U.S. Dollars
Name 2018 Preceding
Period
Year Ago
from Period
Health
2,925.57 2,806.30 2,806.30
Health services
2,778.83 2,665.31 2,665.31
Medical services by disease
2,459.96 2,355.01 2,355.01
Infectious and parasitic diseases
64.90 57.82 57.82
Neoplasms
125.13 143.31 143.31
Endocrine; nutritional; and metabolic diseases and immunity disorders
238.15 234.57 234.57
Mental illness
181.19 159.06 159.06
Diseases of the nervous system and sense organs
204.38 194.87 194.87
Diseases of the circulatory system
290.26 285.38 285.38
Diseases of the respiratory system
158.27 140.67 140.67
Diseases of the digestive system
127.79 125.46 125.46
Diseases of the genitourinary system
111.94 93.97 93.97
Complications of pregnancy; childbirth; and the puerperium
87.02 77.31 77.31
Diseases of the skin and subcutaneous organs
47.32 47.72 47.72
Diseases of the musculoskeletal system and connective tissue
301.83 291.24 291.24
Injury and poisoning
123.10 123.83 123.83
Symptoms; signs; and ill-defined conditions
342.18 325.90 325.90
Other
56.51 53.89 53.89
Diseases of the blood and blood-forming organs
3.35 4.82 4.82
Congenital anomalies
0.00 0.00 0.00
Certain conditions originating in the perinatal period
20.21 21.93 21.93
Residual codes; unclassified; all E codes
32.96 27.14 27.14
Medical services by provider
318.87 310.30 310.30
Dental services
131.81 126.64 126.64
Nursing homes
187.06 183.66 183.66
Proprietary and government nursing homes
128.47 125.39 125.39
Nonprofit nursing homes services to households
58.59 58.27 58.27
Medical products, appliances and equipment
146.74 140.99 140.99
Pharmaceutical and other medical products
77.72 74.85 74.85
Pharmaceutical products (without prescription drugs)
71.59 68.98 68.98
Nonprescription drugs
71.59 68.98 68.98
Other medical products
6.13 5.87 5.87
Therapeutic appliances and equipment
69.01 66.14 66.14
Corrective eyeglasses and contact lenses
37.49 35.94 35.94
Therapeutic medical equipment
31.52 30.20 30.20
   

Subscribe to the FRED newsletter


Follow us

Back to Top